+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Search Bar & Filters

Found 1 Actively Recruiting clinical trials

O

Actively Recruiting

Researchers are evaluating the real-world effectiveness of mavacamten treatment in Chinese adults with symptomatic obstructive hypertrophic cardiomyopathy HCM. This observational study aims to collect data on how mavacamten works in clinical practice for patients diagnosed according to established guidelines, including those with specific heart function and symptom criteria. The study is sponsored by Bristol-Myers Squibb and focuses on patients receiving this treatment based on their clinical needs. Participants in this study have started or will start mavacamten therapy as prescribed by their doctors. The treatment follows the product label recommendations. Data will be collected retrospectively for patients already on mavacamten and prospectively for those initiating treatment. The study includes one main group of participants who will be observed over time while receiving mavacamten. During the study, participants will be monitored up to 96 weeks. Researchers will assess heart function through measurements like the left ventricular outflow tract LVOT gradient and New York Heart Association NYHA class at multiple time points. Medical records, echocardiograms, and other cardiac assessments will be reviewed to track changes. Safety and treatment adherence will be observed as part of routine clinical care throughout the study duration.

Age: 18Years +All Genders
15 locations